HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shinichi Sato Selected Research

Shinichi Sato Research Topics

Disease

143Systemic Scleroderma (Systemic Sclerosis)
11/2022 - 06/2002
57Inflammation (Inflammations)
04/2022 - 03/2002
57Fibrosis (Cirrhosis)
01/2022 - 06/2002
45Neoplasms (Cancer)
11/2022 - 09/2006
36Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022 - 07/2003
29Sclerosis
11/2022 - 06/2002
26Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 10/2008
25Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2022 - 11/2002
21Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2014 - 06/2002
20Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
11/2022 - 12/2011
18Atopic Dermatitis (Atopic Eczema)
09/2022 - 04/2003
16Autoimmune Diseases (Autoimmune Disease)
01/2022 - 10/2005
15Infections
11/2020 - 01/2002
15Urinary Tract Infections (Urinary Tract Infection)
08/2006 - 08/2002
14Hemorrhage
04/2022 - 03/2002
13Contact Dermatitis (Eczema, Contact)
10/2020 - 04/2003
11Dermatitis
09/2022 - 05/2007
11Mycosis Fungoides
11/2021 - 03/2013
11Arthus Reaction
02/2021 - 03/2002
11Dermatomyositis (Dermatopolymyositis)
10/2011 - 04/2003
10Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 10/2008
10Hypertension (High Blood Pressure)
02/2021 - 08/2002
9Edema (Dropsy)
02/2021 - 03/2002
9digital ulcers
11/2020 - 06/2009
9Bullous Pemphigoid (Pemphigoid)
06/2019 - 06/2004
9Coronary Disease (Coronary Heart Disease)
12/2012 - 02/2002
8Melanoma (Melanoma, Malignant)
01/2022 - 12/2005
8Pulmonary Arterial Hypertension
01/2020 - 01/2006
7Localized Scleroderma (Morphea)
08/2020 - 01/2003
7Hypoxia (Hypoxemia)
01/2020 - 04/2010
7Wounds and Injuries (Trauma)
11/2018 - 09/2007
7Ischemic Stroke
11/2014 - 08/2002
7Diffuse Scleroderma (Progressive Systemic Sclerosis)
06/2014 - 04/2003
7Stroke (Strokes)
02/2013 - 08/2002
6Ulcerative Colitis
12/2019 - 10/2006
6Disease Progression
01/2018 - 06/2011
5Pruritus (Itching)
06/2022 - 03/2013
5Cicatrix (Scar)
05/2022 - 06/2004
5Neoplasm Metastasis (Metastasis)
01/2022 - 12/2005
5Telangiectasis (Telangiectasia)
08/2021 - 12/2008
5Vasculitis (Vasculitides)
02/2021 - 06/2009
5Skin Diseases (Skin Disease)
03/2019 - 06/2011
5Connective Tissue Diseases (Connective Tissue Disease)
08/2014 - 10/2005
5Hemorrhagic Stroke
02/2013 - 08/2002
5Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2010 - 06/2007

Drug/Important Bio-Agent (IBA)

42CytokinesIBA
01/2022 - 11/2002
35AutoantibodiesIBA
01/2022 - 06/2002
21Bleomycin (Blenoxane)FDA LinkGeneric
01/2022 - 11/2002
20Proteins (Proteins, Gene)FDA Link
03/2022 - 01/2003
20ChemokinesIBA
01/2022 - 05/2004
19Interleukin-6 (Interleukin 6)IBA
01/2022 - 06/2002
18Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2018 - 03/2002
18EnzymesIBA
05/2018 - 04/2003
18L-SelectinIBA
03/2015 - 03/2002
16LigandsIBA
04/2022 - 08/2004
16AntigensIBA
12/2021 - 07/2005
16Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
03/2015 - 03/2002
15Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2019 - 12/2010
15Anti-Infective Agents (Microbicides)IBA
08/2006 - 08/2002
14Immunoglobulin G (IgG)IBA
02/2021 - 04/2003
13Imiquimod (Aldara)FDA LinkGeneric
01/2022 - 02/2013
13CholesterolIBA
10/2017 - 02/2002
12Interleukin-17 (Interleukin 17)IBA
11/2020 - 06/2008
12ImmunosorbentsIBA
01/2015 - 04/2003
11Messenger RNA (mRNA)IBA
02/2021 - 05/2013
11P-SelectinIBA
12/2013 - 05/2003
10Interleukin-10 (Interleukin 10)IBA
02/2021 - 08/2008
10AntibodiesIBA
02/2021 - 12/2005
9InterleukinsIBA
09/2022 - 07/2016
9C-Reactive ProteinIBA
01/2022 - 05/2006
9SteroidsIBA
12/2020 - 04/2004
9E-SelectinIBA
12/2013 - 05/2003
8anti-scl-70 autoantibodiesIBA
01/2017 - 06/2004
7Rituximab (Mabthera)FDA Link
11/2022 - 01/2014
7Biomarkers (Surrogate Marker)IBA
11/2022 - 04/2010
7Indicators and Reagents (Reagents)IBA
01/2022 - 09/2005
7Type I DNA Topoisomerases (Topoisomerase I)IBA
12/2021 - 01/2004
7Pharmaceutical PreparationsIBA
12/2020 - 12/2005
7AdiponectinIBA
01/2019 - 09/2012
7Transcription Factors (Transcription Factor)IBA
11/2018 - 12/2013
7Antigen-Antibody Complex (Immune Complex)IBA
10/2018 - 08/2004
7indium-bleomycinIBA
01/2018 - 04/2014
7AdipokinesIBA
01/2017 - 05/2013
6Chemotactic FactorsIBA
04/2022 - 07/2003
6Immunoglobulin M (IgM)IBA
06/2021 - 01/2004
6Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
11/2020 - 06/2004
6Biological ProductsIBA
09/2020 - 01/2010
6Immunoglobulin E (IgE)IBA
01/2019 - 05/2004
6SelectinsIBA
11/2011 - 05/2003
5Interleukin-4 (Interleukin 4)IBA
09/2022 - 06/2008
5Monoclonal AntibodiesIBA
04/2022 - 08/2004
5Triglycerides (Triacylglycerol)IBA
04/2022 - 04/2005
5CollagenIBA
01/2022 - 04/2003
5Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022 - 10/2011
5Immunoglobulins (Immunoglobulin)IBA
07/2021 - 01/2008
5Adrenal Cortex Hormones (Corticosteroids)IBA
12/2018 - 01/2010
5HDL CholesterolIBA
02/2013 - 02/2004
5Anti-Bacterial Agents (Antibiotics)IBA
06/2006 - 08/2002

Therapy/Procedure

40Therapeutics
09/2022 - 04/2004
5Drug Therapy (Chemotherapy)
01/2020 - 06/2008